AstraZeneca submits NDA for low dose aspirin/esomeprazole combination product

Links shared publicly online about this topic.

2,068
total visits

AstraZeneca submits NDA for low dose aspirin/esomeprazole combination product

Read how AstraZeneca also submits sNDA for NEXIUM Capsules for risk reduction of low-dose aspirin-associated peptic ulcer.

View full resource at astrazeneca-us.com

Tags: Heartburn Medication, H pylori Infection Medication, Erosive Esophagitis Medication, Peptic Ulcer, Stomach Ulcer Medication, Duodenal Ulcer Medication, Nexium, AstraZeneca

Most Recently Shared on May 4, 2009 at 1:52 pm By:

eyeonfda

AstraZeneca submits NDA for low dose aspirin/esomeprazole combination product - http://twurl.nl/o8w2ad

3 years ago...

Retweet

Favorite

NDA and supplemental NDA submitted for low dose aspirin/esomeprazole (Nexium) combinations - MPR

empr.com — “AstraZeneca announced the submission of a new drug application (NDA) to the FDA for the use of low dose aspirin with Nexium (esomeprazole magnesium) to reduce the risk of low dose aspirin-associated gastric and/or duodenal ulcers in patients at risk of cardio- and cerebrovascular events.” View full resource at empr.com